InvestorsHub Logo
Followers 21
Posts 2457
Boards Moderated 1
Alias Born 09/01/2009

Re: None

Friday, 09/30/2011 1:58:23 PM

Friday, September 30, 2011 1:58:23 PM

Post# of 15861
keep an eye on JAZZ.

always good for a play. 50.00$ should be reachable in the next 2 months imo. recently they aquired a company wich brings them another 100million in revenue this year. Jazz is based in Palo Alto where Apple and Facebook are at home.

Jazz Pharmaceuticals And Azur Pharma Agree To Combine To Form Jazz Pharmaceuticals Plc

– Combined company would have a diversified product portfolio, strong cash flow and expected annual revenues of more than $475 million –
– Jazz Pharmaceuticals stockholders to own slightly under 80 percent of combined entity; Azur Pharma stockholders to own slightly more than 20 percent –
– Conference call today at 4:30 PM ET to discuss transaction –

PALO ALTO, Calif. and DUBLIN, Sept. 19, 2011 /PRNewswire/ — Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) and Azur Pharma Limited today announced that the companies have agreed to combine in an all-stock transaction that creates a specialty pharmaceutical company incorporated in Ireland with a diversified portfolio of products currently marketed in the United States (US). The combined company would be named Jazz Pharmaceuticals plc.

Azur Pharma is a privately-held, profitable specialty pharmaceutical company headquartered in Dublin, Ireland with US operations in Philadelphia. The company markets ten specialty pharmaceutical products in the US in the central nervous system (CNS) and women’s health areas, with expected 2011 net sales of approximately $95 to $100 million.



http://www.dailymarkets.com/stock/2011/09/19/jazz-pharmaceuticals-and-azur-pharma-agree-to-combine-to-form-jazz-pharmaceuticals-plc/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.